737 related articles for article (PubMed ID: 32233763)
21. Polymyalgia rheumatica and its links with giant cell arteritis.
Charlton R
Clin Med (Lond); 2008 Oct; 8(5):498-501. PubMed ID: 18975481
[TBL] [Abstract][Full Text] [Related]
22. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
[TBL] [Abstract][Full Text] [Related]
23. Biomarkers in the era of targeted therapy in giant cell arteritis and polymyalgia rheumatica: is it possible to replace acute-phase reactants?
Carvajal Alegria G; Nicolas M; van Sleen Y
Front Immunol; 2023; 14():1202160. PubMed ID: 37398679
[TBL] [Abstract][Full Text] [Related]
24. Giant Cell Arteritis and Polymyalgia Rheumatica: Treatment Approaches and New Targets.
Nepal D; Putman M; Unizony S
Rheum Dis Clin North Am; 2023 Aug; 49(3):505-521. PubMed ID: 37331730
[TBL] [Abstract][Full Text] [Related]
25. Polymyalgia rheumatica and giant cell arteritis.
Unwin B; Williams CM; Gilliland W
Am Fam Physician; 2006 Nov; 74(9):1547-54. PubMed ID: 17111894
[TBL] [Abstract][Full Text] [Related]
26. Polymyalgia rheumatica: 125 years of progress?
Rooney PJ; Rooney J; Balint G; Balint P
Scott Med J; 2014 Nov; 59(4):220-8. PubMed ID: 25201885
[TBL] [Abstract][Full Text] [Related]
27. Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.
van Sleen Y; Graver JC; Abdulahad WH; van der Geest KSM; Boots AMH; Sandovici M; Brouwer E
Front Immunol; 2019; 10():1981. PubMed ID: 31507597
[TBL] [Abstract][Full Text] [Related]
28. Polymyalgia rheumatica and giant cell arteritis--An ophthalmic emergency.
Durkin SR; Athanasiov PA; Crompton JL
Aust Fam Physician; 2006 Nov; 35(11):889-91. PubMed ID: 17099810
[TBL] [Abstract][Full Text] [Related]
29. [A case of giant cell arteritis after prednisolone dose reduction during treatment of polymyalgia rheumatica].
Yamashita M; Aoki A; Kobayashi H; Wakiya M; Nakatsugawa M
Nihon Ronen Igakkai Zasshi; 2023; 60(4):440-447. PubMed ID: 38171762
[TBL] [Abstract][Full Text] [Related]
30. Pathogenesis, Diagnosis and Management of Polymyalgia Rheumatica.
Camellino D; Giusti A; Girasole G; Bianchi G; Dejaco C
Drugs Aging; 2019 Nov; 36(11):1015-1026. PubMed ID: 31493201
[TBL] [Abstract][Full Text] [Related]
31. Non-giant cell arteritis of the temporal artery presenting as the polymyalgia rheumatica-temporal arteritis syndrome.
Lesser RS; Aledort D; Lie JT
J Rheumatol; 1995 Nov; 22(11):2177-82. PubMed ID: 8596167
[TBL] [Abstract][Full Text] [Related]
32. Polymyalgia rheumatica and giant cell arteritis. The dilemma of therapy.
Wilske KR; Healey LA
Postgrad Med; 1985 Jun; 77(8):243-8. PubMed ID: 4001042
[TBL] [Abstract][Full Text] [Related]
33. [Polymyalgia rheumatica: myalgic syndrome or occult vasculitis?].
Hellmich B; Gross WL
Internist (Berl); 2005 Nov; 46(11):1233-43. PubMed ID: 16151786
[TBL] [Abstract][Full Text] [Related]
34. Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica.
Camellino D; Matteson EL; Buttgereit F; Dejaco C
Nat Rev Rheumatol; 2020 Sep; 16(9):481-495. PubMed ID: 32759996
[TBL] [Abstract][Full Text] [Related]
35. Discontinuation of therapies in polymyalgia rheumatica and giant cell arteritis.
Muratore F; Pipitone N; Hunder GG; Salvarani C
Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S86-92. PubMed ID: 24129145
[TBL] [Abstract][Full Text] [Related]
36. [Recommendations of diagnosis and treatment of giant cell arteritis and polymyalgia rheumatic in China].
Wang P; Feng XB; Duan XW; Liu SY; Zhao Y
Zhonghua Nei Ke Za Zhi; 2023 Mar; 62(3):256-266. PubMed ID: 36822851
[TBL] [Abstract][Full Text] [Related]
37. Highlights in clinical medicine-Giant cell arteritis, polymyalgia rheumatica and Takayasu's arteritis: pathogenic links and therapeutic implications.
Solimando AG; Vacca A; Dammacco F
Clin Exp Med; 2022 Nov; 22(4):509-518. PubMed ID: 34741677
[TBL] [Abstract][Full Text] [Related]
38. Clinical features of polymyalgia rheumatica and giant cell arteritis.
Salvarani C; Pipitone N; Versari A; Hunder GG
Nat Rev Rheumatol; 2012 Sep; 8(9):509-21. PubMed ID: 22825731
[TBL] [Abstract][Full Text] [Related]
39. Polymyalgia rheumatica and temporal arteritis.
Allen NB; Studenski SA
Med Clin North Am; 1986 Mar; 70(2):369-84. PubMed ID: 3512931
[TBL] [Abstract][Full Text] [Related]
40. Polymyalgia rheumatica: 125 years of epidemiological progress?
Rooney PJ; Rooney J; Balint G; Balint P
Scott Med J; 2015 Feb; 60(1):50-7. PubMed ID: 25201886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
